There's always some consternation before a launch on Amazon
There's always some consternation before a launch on Amazon or e commerce site for a small, developing company. Is it going to happen? Is it real? Will there be delays, etc.
I appreciate investors going the extra step and making calls and doing research and yes, reps conversations from Amazon can be, "on the spot," informational pieces that can be picked up from an amicable chat.
It's not one size fits all with them.
Bottom line with the minutiae is we have plenty of layers to suggest that Amazon is going to happen, her e commerce site is going to launch and she will make a concerted effort to penetrate US markets with her product.
That's good enough for me to hold strong for several months to see the direction this takes.
1
Bemax Inc. (BMXCD) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
MediaAlpha's Upcoming Financial Report Announcement MediaAlpha, Inc. (NYSE: MAX), based in Los Angeles, has exciting news for its investors and stakeholders. The company is gearing up to announce its financial results for the third quarter of 2024 on an upcoming Wednesday. This announcement will take place after the market closes, providing important insights into the...
Continue Reading
BigID Launches Innovative Solutions for AI Data Access Control Organizations are increasingly leveraging technology in ways that enhance workflows while prioritizing data security. BigID, a leader in the realm of data security and privacy, has introduced a groundbreaking method to prevent unauthorized access to sensitive information in Artificial Intelligence (AI)...
Continue Reading
Latigo Biotherapeutics Secures Major Funding for Pain Relief Advancement Latigo Biotherapeutics, a clinical-stage biotechnology firm dedicated to creating leading non-opioid pain management solutions, has officially closed a substantial $150 million in Series B financing. This funding round aims to push forward the development of their innovative Nav1.8 inhibitor...
Continue Reading
WisdomTree's Strategic Shift in UK Equity Income In a significant move, the Directors of WisdomTree Issuer ICAV have officially announced plans to delist the WisdomTree UK Equity Income UCITS ETF. This decision comes as the company aims to merge its focus towards investing in UK Quality Dividend Growth strategies. The shares of this Sub-Fund will no longer be available...
Continue Reading
Avista Foundation's Generous Grants in 2024 In its recent fourth-quarter granting cycle, the Avista Foundation has showcased its unwavering commitment to enhancing community welfare. The foundation distributed a remarkable total of $54,650 to 21 nonprofit organizations across various initiatives aimed at promoting environmental sustainability and enriching arts and...
Continue Reading
